» Articles » PMID: 29921667

Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A

Overview
Journal mBio
Specialty Microbiology
Date 2018 Jun 21
PMID 29921667
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The Epstein-Barr virus (EBV) oncoproteins latent membrane protein 1 (LMP1) and LMP2A constitutively activate multiple signaling pathways, and both have been shown to interact with cellular ubiquitin ligases and affect cellular ubiquitination. To detect the LMP1- and LMP2A-mediated effects on the global cellular proteome, epithelial cell lines expressing LMP1 or LMP2A were analyzed using label-free quantitative proteomics. To identify proteins whose ubiquitination is affected by the viral proteins, the cells were cultured in the presence and absence of deubiquitinase (DUB) and proteasome inhibitors. More than 7,700 proteins were identified with high confidence and considerably more proteins showed significant differences in expression in the presence of inhibitors. Few of the differentially expressed proteins with or without inhibitors were common between LMP1 and LMP2A, confirming that the viral proteins induce unique changes in cell expression and function. However, ingenuity pathway analysis (IPA) of the data indicated that LMP1 and LMP2A modulate many of the same cellular regulatory pathways, including cell death and survival, cell movement, and actin filament dynamics. In addition, various proteasome subunits, ubiquitin-specific peptidases and conjugating enzymes, vesicle trafficking proteins, and NF-κB and mitogen-activated protein kinase signaling proteins were affected by LMP1 or LMP2A. These findings suggest that LMP1 and LMP2A may commonly target critical cell pathways through effects on distinct genes, with many cellular proteins modified by ubiquitination and/or degradation. The Epstein-Barr virus proteins latent membrane protein 1 and 2 have potent effects on cell growth and signaling. Both proteins bind to specific ubiquitin ligases and likely modulate the cellular proteome through ubiquitin-mediated effects on stability and intracellular location. In this study, a comprehensive proteomic analysis of the effects of LMP1 and LMP2A revealed that both proteins affected proteasome subunits, ubiquitin-specific conjugases and peptidases, and vesical trafficking proteins. The data suggest that the effects of these proteins on the abundance and ubiquitination of cellular proteins are in part responsible for their effects on cell growth regulation.

Citing Articles

Ubiquitin-specific peptidases in lymphoma: a path to novel therapeutics.

Samareh Salavatipour M, Tavakoli S, Halimi A, Tavoosi S, Baghsheikhi A, Talebi-Taheri A Front Pharmacol. 2024; 15:1356634.

PMID: 39664521 PMC: 11632177. DOI: 10.3389/fphar.2024.1356634.


Awakening the sleeping giant: Epstein-Barr virus reactivation by biological agents.

Indari O, Ghosh S, Bal A, James A, Garg M, Mishra A Pathog Dis. 2024; 82.

PMID: 38281067 PMC: 10901609. DOI: 10.1093/femspd/ftae002.


Role of Exosomes and Their Potential as Biomarkers in Epstein-Barr Virus-Associated Gastric Cancer.

Kim B, Kim K Cancers (Basel). 2023; 15(2).

PMID: 36672418 PMC: 9856651. DOI: 10.3390/cancers15020469.


Epstein-Barr virus latency programs dynamically sensitize B cells to ferroptosis.

Burton E, Voyer J, Gewurz B Proc Natl Acad Sci U S A. 2022; 119(11):e2118300119.

PMID: 35275790 PMC: 8931387. DOI: 10.1073/pnas.2118300119.


The Central Role of the Ubiquitin-Proteasome System in EBV-Mediated Oncogenesis.

Pei Y, Robertson E Cancers (Basel). 2022; 14(3).

PMID: 35158879 PMC: 8833352. DOI: 10.3390/cancers14030611.


References
1.
Zhang X, Wang W, Wang H, Wang M, Xu W, Zhang R . Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop. Oncogene. 2012; 32(22):2782-91. PMC: 6714567. DOI: 10.1038/onc.2012.289. View

2.
Schafer J, McRae R, Manning E, Lapierre L, Goldenring J . Rab11-FIP1A regulates early trafficking into the recycling endosomes. Exp Cell Res. 2016; 340(2):259-73. PMC: 4744548. DOI: 10.1016/j.yexcr.2016.01.003. View

3.
CALDWELL R, Wilson J, Anderson S, Longnecker R . Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity. 1998; 9(3):405-11. DOI: 10.1016/s1074-7613(00)80623-8. View

4.
Rodriguez M, Egana I, Lopitz-Otsoa F, Aillet F, Lopez-Mato M, Dorronsoro A . The RING ubiquitin E3 RNF114 interacts with A20 and modulates NF-κB activity and T-cell activation. Cell Death Dis. 2014; 5:e1399. PMC: 4454333. DOI: 10.1038/cddis.2014.366. View

5.
Portis T, Dyck P, Longnecker R . Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2003; 102(12):4166-78. DOI: 10.1182/blood-2003-04-1018. View